메뉴 건너뛰기




Volumn 37, Issue 3-4, 2011, Pages 216-221

Huntington's disease: Current epidemiology and pharmacological management in UK primary care

Author keywords

Huntington's disease; Incidence and prevalence; Neuroepidemiology; Pharmacoepidemiology

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT;

EID: 82355184595     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000331912     Document Type: Article
Times cited : (17)

References (13)
  • 2
    • 78049277912 scopus 로고    scopus 로고
    • Huntington's disease out of the closet?
    • Rawlins M: Huntington's disease out of the closet? Lancet 2010; 376: 1372-1373.
    • (2010) Lancet , vol.376 , pp. 1372-1373
    • Rawlins, M.1
  • 3
    • 0026684333 scopus 로고
    • The epidemiology of Huntington's disease
    • Harper PS: The epidemiology of Huntington's disease. Human Genetics 1992; 89: 365-376.
    • (1992) Human Genetics , vol.89 , pp. 365-376
    • Harper, P.S.1
  • 4
    • 77954746528 scopus 로고    scopus 로고
    • Stigma, history, and Huntington's disease
    • Wexler A: Stigma, history, and Huntington's disease. Lancet 2010; 376: 18-19.
    • (2010) Lancet , vol.376 , pp. 18-19
    • Wexler, A.1
  • 6
    • 0029098272 scopus 로고
    • The epidemiology of Huntington's disease in Northern Ireland
    • Morrison PJ, Johnston WP, Nevin NC: The epidemiology of Huntington's disease in Northern Ireland. J Med Genet 1995; 32: 524-530.
    • (1995) J Med Genet , vol.32 , pp. 524-530
    • Morrison, P.J.1    Johnston, W.P.2    Nevin, N.C.3
  • 7
    • 84855708016 scopus 로고    scopus 로고
    • EPIC, Accessed June
    • EPIC: Http://www.epic-uk.org/advantages. htm. Accessed June 2008.
    • (2008)
  • 8
    • 25844453682 scopus 로고    scopus 로고
    • Joint Formulary Committee, 59 ed London, British Medical Association and Royal Pharmaceutical Society of Great Britain
    • Joint Formulary Committee: British National Formulary, 59 ed. London, British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010.
    • (2010) British National Formulary
  • 9
    • 68249143292 scopus 로고    scopus 로고
    • A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
    • Dhaenens C, Burnouf S, Simonin C: A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis 2009; 35: 474-476.
    • (2009) Neurobiol Dis , vol.35 , pp. 474-476
    • Dhaenens, C.1    Burnouf, S.2    Simonin, C.3
  • 10
    • 0004293147 scopus 로고
    • A Disorder of Families. Baltimore, Johns Hopkins University Press
    • Folstein S: Huntington's Disease. A Disorder of Families. Baltimore, Johns Hopkins University Press, 1984.
    • (1984) Huntington's Disease
    • Folstein, S.1
  • 12
    • 77950960665 scopus 로고    scopus 로고
    • Early testing for Huntington disease in children: Pros and cons
    • Toufexis M, Gieron-Korthals M: Early testing for Huntington disease in children: Pros and cons. J Child Neurol 2010; 25: 482-484.
    • (2010) J Child Neurol , vol.25 , pp. 482-484
    • Toufexis, M.1    Gieron-Korthals, M.2
  • 13
    • 33846225133 scopus 로고    scopus 로고
    • Huntington's disease
    • DOI 10.1016/S0140-6736(07)60111-1, PII S0140673607601111
    • Walker FO: Huntington's disease. Lancet 2007; 369: 218-228. (Pubitemid 46107685)
    • (2007) Lancet , vol.369 , Issue.9557 , pp. 218-228
    • Walker, F.O.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.